✦ LIBER ✦

Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US

✍ Scribed by Samuel Aballéa; Jeremy V.M. Chancellor; Maria Raikou; Michael F. Drummond; Milton C. Weinstein; Sophia Jourdan; John Bridgewater

Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 148 KB
Volume: 109
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.22512

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe enteropathy among patients with s

Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin : A prospective analysis

✍ J. Philip Kuebler; Linda Colangelo; Michael J. O'Connell; Roy E. Smith; Greg Yot 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 1 views

## Abstract ## BACKGROUND. Cases of severe gastrointestinal toxicity were monitored prospectively during NSABP C‐07, a randomized clinical trial of adjuvant therapy for patients with stage II/III colon cancer. ## METHODS. Patients were treated with weekly bolus 5‐fluorouracil (5‐FU) and leucovor

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views